Cefepime compared with ceftazidime as initial therapy for serious bacterial infections and sepsis syndrome.

In an open randomized multicenter comparative study, we evaluated the safety and efficacy of cefepime (CP; 2.0 g given intravenously every 12 h) and ceftazidime (CZ; 2.0 g given intravenously every 8 h) as initial treatment for adult patients with suspected serious bacterial infections. A total of 1...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Kieft, H, Hoepelman, A I, Rozenberg-Arska, M, Branger, J M, Voskuil, J H, Geers, A B, Kluyver, M, Hart, H C, Poest-Clement, E, van Beugen, L
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology (ASM) 1994
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284473/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8203833/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.3.415
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars